1 Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD. 2 Currently, Division of Special Pathogen and Transplant Products, Food and Drug Administration, Silver Spring, MD. 3 Currently, Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH. 4 Address correspondence to: Barbara A. Wasowska, Ph.D., 720 Rutland Avenue, Ross Building, #664B, Baltimore, MD 21205.
Transplantation. 2013 Oct 15;96(7):601-8. doi: 10.1097/TP.0b013e31829c2455.
Alloantibody can contribute significantly to rejection of heart transplants by activation of complement and interactions with a variety of effector cells, including macrophages and monocytes through activating FcγRI, FcγRIII, FcγRIV, the inhibitory FcγRIIB and complement receptors. These receptors link cellular and humoral immunity by bridging the antibody specificity to effector cells. Activating FcγRs are also involved in serum amyloid P component (SAP)-mediated clearance of apoptotic bodies.
B10.A (H-2a) hearts were transplanted into wild-type (WT) or FcγRIII-knockout (KO) C57BL/6 (H-2b) mouse recipients. Levels of alloantibodies and SAP in the circulation were determined by flow cytometry and enzyme-linked immunosorbent assay, respectively. Intragraft cytokine mRNA expression was measured by real-time polymerase chain reaction. Intragraft deposition of C4d, von Willebrand factor, SAP, and activated caspase 3 was visualized by immunochemistry.
B10.A hearts in C57BL/6 FcγRIII-KO recipients were rejected acutely within 6 to 8 days compared with 10 to 14 days in WT. The rejection in FcγRIII-KO was accompanied by higher levels of circulating IgM/IgG alloantibodies and SAP than in WT recipients. Histology in FcγRIII-KO cardiac allograft recipients indicated perivascular margination of monocytes and neutrophils, vascular endothelial cell injury, and intense vasculocentric infiltrates with extensive apoptosis. Higher numbers of apoptotic cells, stronger C4d and SAP deposition, and extensive activated caspase 3 were found in areas of dense pockets of apoptotic blebs in FcγRIII-KO.
We propose that absence of FcγRIII is associated with the lack of efficient SAP-mediated clearance of apoptotic cells through FcγRs. Apoptotic cells become immunogenic and induce enhanced inflammation, alloantibody production, and complement activation leading to accelerated cardiac allograft rejection.
同种异体抗体通过激活补体和与各种效应细胞(包括巨噬细胞和单核细胞)相互作用,可显著导致心脏移植排斥反应。这些效应细胞通过将抗体特异性与效应细胞桥接,将细胞和体液免疫联系起来。其中包括 FcγRI、FcγRIII、FcγRIV、抑制性 FcγRIIB 和补体受体。激活的 FcγRs 还参与血清淀粉样蛋白 P 成分 (SAP) 介导的凋亡小体清除。
将 B10.A(H-2a)心脏移植到野生型(WT)或 FcγRIII 敲除(KO)C57BL/6(H-2b)小鼠受体中。通过流式细胞术和酶联免疫吸附试验分别测定循环中的同种异体抗体和 SAP 水平。通过实时聚合酶链反应测量移植组织内细胞因子 mRNA 的表达。通过免疫化学观察移植组织内 C4d、血管性血友病因子、SAP 和活化的 caspase 3 的沉积。
与 WT 受体相比,C57BL/6 FcγRIII-KO 受体中的 B10.A 心脏在 6 至 8 天内急性排斥,而在 WT 受体中为 10 至 14 天。FcγRIII-KO 中的排斥反应伴有循环 IgM/IgG 同种异体抗体和 SAP 水平高于 WT 受体。FcγRIII-KO 心脏移植物受体的组织学检查显示单核细胞和中性粒细胞沿血管边缘排列,血管内皮细胞损伤,血管中心浸润广泛,凋亡明显。在 FcγRIII-KO 中,凋亡小泡密集区的凋亡细胞数量较多,C4d 和 SAP 沉积较强,活化的 caspase 3 广泛存在。
我们提出,缺乏 FcγRIII 与 SAP 通过 FcγRs 介导的清除凋亡细胞效率低下有关。凋亡细胞变得具有免疫原性,并诱导增强的炎症、同种异体抗体产生和补体激活,导致心脏移植物排斥反应加速。